Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis.
about
Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODSElevated calcitonin precursor levels are related to mortality in an animal model of sepsisMass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failureMeasurements in the intensive care unit: what do they mean?Prognostic categorization of intensive care septic patientsProcalcitonin in liver transplantation: are high levels due to donors or recipients?The era of molecular and other non-culture-based methods in diagnosis of sepsisLeucocyte activation markers in clinical practice.Molecular aspects and natural source of procalcitonin.Procalcitonin as a prognostic marker for sepsis: a prospective observational study.Procalcitonin neutralizes bacterial LPS and reduces LPS-induced cytokine release in human peripheral blood mononuclear cells.Procalcitonin predicts mortality in HIV-infected Ugandan adults with lower respiratory tract infections.Plasma procalcitonin is associated with all-cause and cancer mortality in apparently healthy men: a prospective population-based study.Procalcitonin beyond the acute phase: novel biomediator properties?Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patientsProcalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study.Diagnostic value of serum procalcitonin level in differentiating bacterial from nonbacterial meningitis in children.Adipocyte, adipose tissue, and infectious disease.Elevated Serum PCT in Septic Shock With Endotoxemia Is Associated With a Higher Mortality Rate.Use of procalcitonin in patients on chronic hemodialysis: procalcitonin is not related with increased serum calcitonin.Epigenetic regulation of the calcitonin gene-related peptide gene in trigeminal glia.Procalcitonin as a biomarker in equine chronic pneumopathiesA comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study.Deletion of the gene encoding calcitonin and calcitonin gene-related peptide α does not affect the outcome of severe infection in mice.Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcomePresepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.Reactive oxygen species induce procalcitonin expression in trigeminal ganglia gliaProcalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.Use of plasma procalcitonin levels as an adjunct to clinical microbiology.Procalcitonin for guidance of antibiotic therapy.Procalcitonin as a biomarker in respiratory tract infection.Procalcitonin-guided antibiotic treatment of respiratory tract infections in a primary care setting: are we there yet?Immune regulation of procalcitonin: a biomarker and mediator of infection.Streamlining antibiotic therapy with procalcitonin protocols: consensus and controversies.Is serum procalcitonin measurement a useful addition to a rheumatologist's repertoire? A review of its diagnostic role in systemic inflammatory diseases and joint infections.Procalcitonin Impairs Liver Cell Viability and Function In Vitro: A Potential New Mechanism of Liver Dysfunction and Failure during Sepsis?Intravenous immunoglobulin prevents release of proinflammatory cytokines in human monocytic cells stimulated with procalcitonin.The relationship between the MEFV genotype, clinical features, and cytokine-inflammatory activities in patients with familial mediterranean fever.The Determination of Procalcitonin Concentration in Early-Onset Neonatal Infection.Plasma concentrations of copeptin, C-reactive protein and procalcitonin are positively correlated with APACHE II scores in patients with sepsis.
P2860
Q22000231-3CD135D8-3183-4F71-9D14-DABACD6F5EE1Q24793821-D8ADCE88-0D0C-4D61-821D-14DA1AE84965Q24802183-B3862F71-9905-4041-813E-00E585C638D5Q24802598-8AEBA696-59DA-40F7-9454-C582C75DB5D5Q26825553-B0B67180-3335-4447-9A50-C40456A444DAQ33349213-9DADAE1B-711A-4838-8D43-A6209F6441DFQ33591270-4CBA47E3-8958-4E0B-B97F-00D187B4CBC1Q33727381-AB9396D1-76FD-42CC-AED3-8C4907E5C4BFQ33760702-A2F0A67F-83C3-4617-87B1-7A2F74828129Q33926563-136CD062-736B-4E35-839C-A6390FAAAC97Q34262422-88D3D326-F10F-4FFF-AD1E-01CDFE7173CFQ34773984-822E50CB-3D17-4AB8-AB92-04A1C4B387F0Q34929410-D06532DF-7A2B-4735-B4AD-8181E1AC537FQ34975737-AC3FA650-5C28-4553-BEC2-84BB599D5B12Q34999108-F592B841-7990-4774-9A92-0D931C177D74Q34999385-266DCBAF-B733-4B12-B234-B52B3F211C8EQ35642799-9C54F355-F976-4338-9198-48E0DE5F5213Q35689443-37F76313-59F6-48EA-A5E6-9105345BD66AQ35857871-B65EF5E4-C236-4FFB-A2B2-5DFCCE0497D3Q35998084-1B77796E-BDF9-4C40-9D9E-108DCB91D9E8Q36060346-02B38118-606D-482C-B08A-81CD475BA7EEQ36219190-771CB7F6-DFE5-46D4-8A22-01666C73FE86Q36392734-3D8DC059-F327-4453-98C9-70C60FE61CE6Q37056486-1FE45DEB-DFC8-445D-AB8B-C7CA6F39E35CQ37210066-CE5CA689-EEC9-4EAB-8702-4D880A206791Q37411315-6AE54E21-113D-4A81-92F5-60BE926DE70DQ37627012-72293C59-A360-4B6D-B483-3B0560908C02Q37650812-BA2FC584-C3B7-4B11-88F4-2B79EC760852Q37737480-8BAC58F5-B280-4376-9A7F-E98A0D959F1FQ37747406-AB62A6A8-F437-4091-9428-C3E01C07A3A2Q37860806-750A652D-768F-4D5A-80D8-6C07A1763CFAQ37910003-9223A1D5-CB05-44F2-9CEC-8ACE3B728712Q37987042-6B69A259-B78D-4413-BFBF-F7F555622780Q38095145-9DD058B7-1EF7-4017-A9E7-5E4D21B07D44Q38263160-0C242EA8-1415-4B42-8F4E-90B1501E287BQ38714059-C7723147-D913-46B6-AF64-D2CB057B12C9Q39392633-6568CB78-CFDB-402D-8B51-6AC6810850AFQ40426204-B74F26B6-0A95-4E48-8D68-A3921ECD1DD1Q40631876-2DF6D662-D417-46F9-BE1F-8D7246F14604Q41477861-0146CBBB-7387-4E25-89E0-32DC6CFD28B0
P2860
Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Mortality is increased by proc ...... itonin in experimental sepsis.
@en
Mortality is increased by proc ...... itonin in experimental sepsis.
@nl
type
label
Mortality is increased by proc ...... itonin in experimental sepsis.
@en
Mortality is increased by proc ...... itonin in experimental sepsis.
@nl
prefLabel
Mortality is increased by proc ...... itonin in experimental sepsis.
@en
Mortality is increased by proc ...... itonin in experimental sepsis.
@nl
P2093
P1476
Mortality is increased by proc ...... itonin in experimental sepsis.
@en
P2093
K L Becker
P M Steinwald
R H Snider
P304
P356
10.1097/00003246-199806000-00015
P407
P577
1998-06-01T00:00:00Z